M&A Deal Summary

Prinses Maxima Center Acquires Volta Labs - Callisto Platform

On September 10, 2025, Prinses Maxima Center acquired life science company Volta Labs - Callisto Platform from Volta Labs

Acquisition Highlights
  • This is Prinses Maxima Center’s 1st transaction in the Life Science sector.
  • This is Prinses Maxima Center’s 1st transaction in the United States.
  • This is Prinses Maxima Center’s 1st transaction in Massachusetts.

M&A Deal Summary

Date 2025-09-10
Target Volta Labs - Callisto Platform
Sector Life Science
Buyer(s) Prinses Maxima Center
Sellers(s) Volta Labs
Deal Type Divestiture

Target

Volta Labs - Callisto Platform

Boston, Massachusetts, United States
Volta Labs' Callisto Platform helps streamline sample preparation across multiple genomics workflows, supporting both Illumina and Oxford Nanopore Technologies (ONT) sequencing platforms. Volta Labs' Callisto Platform is based in Boston, Massachusetts.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Prinses Maxima Center

Utrecht, Netherlands

Category Company
Sector Healthcare Services
DESCRIPTION

Prinses Maxima Center provides an integrated combination of specialized pediatric cancer care, scientific research, and education/training. Prinses Maxima Center is based in Utrecht, Netherlands.


DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Divestiture M&A Deals 1 of 1
State: Massachusetts M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2025 M&A 1 of 1

Seller(S) 1

SELLER

Volta Labs

Boston, Massachusetts, United States

Category Company
Sector Life Science
DESCRIPTION

Volta Labs is a genomics applications company that has developed a cutting-edge digital fluidics platform to maximize the performance and scalability of sample preparation in genomics while providing unparalleled consistency. Volta Labs is based in Boston, Massachusetts.


DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Divestiture M&A Deals 1 of 1
State: Massachusetts M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2025 M&A 1 of 1